What Is Hepatic Malignant Mixed Tumour?
Hepatic malignant mixed tumour is a rare type of liver cancer characterized by the presence of both epithelial and mesenchymal components. This means the tumour contains cells that are characteristic of both glandular tissues (epithelial cells) and connective tissues (mesenchymal cells), making it a complex and diverse form of cancer. Due to its rarity, there is limited specific information, and it is often considered under the broader category of liver cancers or sarcomatoid carcinomas when discussing treatment and prognosis.
Symptoms
Symptoms of hepatic malignant mixed tumour can be similar to other forms of liver cancer and may include:
- Unexplained weight loss
- Loss of appetite
- Abdominal pain or discomfort, especially in the upper right side
- A palpable mass in the abdomen
- Jaundice (yellowing of the skin and eyes)
- Ascites (accumulation of fluid in the abdomen)
- General weakness and fatigue
Disease Aetiology (Causes)
The exact cause of hepatic malignant mixed tumours is unknown. Factors that may increase the risk of liver cancer, in general, include chronic hepatitis B or C infection, cirrhosis, exposure to aflatoxins, heavy alcohol use, and nonalcoholic fatty liver disease.
Diagnosis
Diagnosing a hepatic malignant mixed tumour involves a combination of imaging, laboratory tests, and histological examination:
- Imaging studies such as ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI) are used to identify and assess the extent of liver tumours.
- Blood tests, including liver function tests and tumour markers, may help in the diagnosis and monitoring of liver cancers.
- A biopsy is essential for confirming the diagnosis by allowing microscopic examination of the tumour cells to identify the presence of both epithelial and mesenchymal components.
Treatment
Treatment options for hepatic malignant mixed tumour depend on the stage of the cancer, the overall health of the patient, and the specific characteristics of the tumour:
- Surgery is the primary treatment when the tumour is localized and resectable, aiming to remove the tumour completely.
- Chemotherapy and radiation therapy may be used, especially if the tumour is unresectable, to shrink the tumour size and alleviate symptoms.
- Targeted therapy and immunotherapy are emerging treatment options that may be considered based on the tumour’s molecular profile.
- Liver transplantation might be an option in select cases where the cancer is localized to the liver and meets specific criteria.
What support can we give for the Hepatic Malignant Mixed Tumour?
Hepatic Malignant Mixed Tumour is a rare cancer, meaning it is not as well-known as other forms of cancer. Without a Ribbon is an Australian organisation that provides support for individuals who suffer from rare cancers. So, we provide a designated platform for Warriors to obtain information specific to their Rare Cancer. We also provide annual opportunities for our Warriors to meet and learn from each other. If you suffer from rare cancer such as Hepatic Malignant Mixed Tumour, we can help and support you through your journey thanks to the generous donations we receive. Click the link below to sign up and become a Warrior today!
You can help us with your donation:
Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:
